Skip to main content
SpringerLink
Log in

Epidemiology and Health Care Costs for Diabetic Foot Problems

  • Chapter
The Diabetic Foot

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

The global prevalence of diabetes is predicted to double by the year 2030 from 2.8% to 4.4% (1). Of individuals with diabetes, a substantial number will develop lower extremity disease including peripheral neuropathy, foot ulcers, and peripheral arterial disease (PAD). In this chapter, the current epidemiology of lower extremity disease in individuals with diabetes is reviewed with a focus on foot ulcers. Population-based and hospital discharge survey data from several sources illustrate the magnitude of the problem in the United States. Analytic and experimental studies conducted in several countries, which used robust multivariable modeling techniques, are discussed to describe foot ulcer risk factors. The chapter concludes with information on the economic impact of lower extremity disease, primarily diabetic foot ulcers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047–1053.

    Article  PubMed  Google Scholar 

  2. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the U.S. adult population &gd;40 years of age with and without diabetes. Diabetes Care 2004;27(7):1591–1597.

    Article  PubMed  Google Scholar 

  3. ICD-9-CM Professional for Hospitals, (2004), International Classification of Diseases. (Hart AC, Hopkins CA, eds.), Volumes 1–3, 6th ed., St. Anthony Publishing/Medicode, Ingenix, 2003.

    Google Scholar 

  4. CDC. Data & Trends—Diabetes Surveillance System—Hospitalizations for Lower Extremity Conditions: Methodology. National Center for Chronic Disease Prevention and Health Promotion, Diabetes Public Health Resource, Available at: http://www.cdc.gov/diabetes/statistics/hosplea/methods.htm [accessed 7/05]; 2005.

  5. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489–493.

    Article  PubMed  CAS  Google Scholar 

  6. AHRQ. Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample, 2001, 2002. Available at: http://www.hcup-us.ahrq.gov (accessed 7/05).

  7. Palumbo P, Melton L. Peripheral Vascular Disease and Diabetes. US Government Printing Office, Washington, DC, 1985.

    Google Scholar 

  8. Reiber G, Vileikyte L, Boyko E, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22(1):157–162.

    Article  PubMed  CAS  Google Scholar 

  9. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 1997;14(10):867–870.

    Article  PubMed  CAS  Google Scholar 

  10. Apelqvist J, Castenfors J, Larsson J. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 1989;6:526–530.

    PubMed  CAS  Google Scholar 

  11. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998;176(2A):5S–10S.

    Article  PubMed  CAS  Google Scholar 

  12. Kumar S, Ashe HA, Fernando DJS, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994;11:480–484.

    PubMed  CAS  Google Scholar 

  13. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. Diabetes Care 1992;15(10):1386–1389.

    Article  PubMed  CAS  Google Scholar 

  14. Walters DP, Gatling W, Mullee MA, Hill RD. The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabet Med 1992;9:354–358.

    PubMed  CAS  Google Scholar 

  15. Moss SE, Klein R, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992;152:610–616.

    Article  PubMed  CAS  Google Scholar 

  16. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998;21:1071–1075.

    Article  PubMed  CAS  Google Scholar 

  17. Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377–384.

    Article  PubMed  CAS  Google Scholar 

  18. Carrington AL, Shaw JE, Van Schie CHM, Abbott CA, Vileikyte L, Boulton AJM. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002;25(11):2010–2015.

    Article  PubMed  Google Scholar 

  19. Boyko E, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036–1042.

    Article  PubMed  CAS  Google Scholar 

  20. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini J, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606–611.

    Article  PubMed  CAS  Google Scholar 

  21. Frykberg RG, Lavery LA, Pham HT, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998;21(10):1714–1719.

    Article  PubMed  CAS  Google Scholar 

  22. Litzelman DK, Marriott RJ, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Diabetes Care 1997;20(2):156–162.

    Article  PubMed  CAS  Google Scholar 

  23. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;20(8):1273–1278.

    Article  PubMed  CAS  Google Scholar 

  24. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1993;119(1):36–41.

    PubMed  CAS  Google Scholar 

  25. Maciejewski ML, Reiber GE, Smith DG, Wallace C, Hayes S, Boyko EJ. The effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care 2004;27:1774–1782.

    Article  PubMed  Google Scholar 

  26. Mantey I, Foster AVM, Spencer S, Edmonds ME. Why do foot ulcers recur in diabetic patients. Diabet Med 1999;16:245–249.

    Article  PubMed  CAS  Google Scholar 

  27. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larson J. Diabetic foot ulcers in a multidis-ciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994;235:463–471.

    Article  PubMed  CAS  Google Scholar 

  28. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22(3):382–387.

    Article  PubMed  CAS  Google Scholar 

  29. Ortegon MM, Redkop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot. Diabetes Care 2004;27:901–907.

    Article  PubMed  Google Scholar 

  30. HCFA. DRG Inpatient Billing Data, 2002: Health Care Finance Administration, Bureau of Data Strategy and Management, 2005.

    Google Scholar 

  31. MEDSTAT. DRG Guide Descriptions and Normative Values. Ann Arbor, MI, 2005.

    Google Scholar 

  32. Borssen B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet Med 1990;7:438–444.

    PubMed  CAS  Google Scholar 

  33. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 2003;26(4):1069–1073.

    Article  PubMed  Google Scholar 

  34. Malgrange D, Richard JL, Leymarie F. Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France. Diabetes Metab 2003;29(3):261–268.

    Article  PubMed  CAS  Google Scholar 

  35. MMWR. History of foot ulcer among persons with diabetes—United States 2000-2002. Morb Mortal Wkly Rep 2003;52(45):1098–1102.

    Google Scholar 

  36. Apelqvist J, Larsson J, Agard C. Long term prognosis for diabetic patients with foot ulcers. J Int Med 1993;233:485–491.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Health Services and Epidemiology, University of Washington, Seattle, WA

    Gayle E. Reiber MPH, PhD (VA Career Scientist and Professor)

  2. Department of Medicinal Chemistry, University of Washington, Seattle, WA

    Lynne V. McFarland MS, PhD (VA Research Health Science Specialist and Affiliate Associate Professor)

Authors
  1. Gayle E. Reiber MPH, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynne V. McFarland MS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Aristidis Veves MD, DSc , John M. Giurini DPM  & Frank W. Logerfo MD ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Reiber, G.E., McFarland, L.V. (2006). Epidemiology and Health Care Costs for Diabetic Foot Problems. In: Veves, A., Giurini, J.M., Logerfo, F.W. (eds) The Diabetic Foot. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59745-075-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-075-1_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-610-8

  • Online ISBN: 978-1-59745-075-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation